Tagrisso 80 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4E7T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,876
Award facts
- Contract value 100% obligated
- $24,876.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 9, 2026, by the Defense Logistics Agency to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.), procures 30-count tablets of Tagrisso 80 mg, an oncology medication used to treat non-small cell lung cancer. The contract is valued at $24,876.30 with a firm fixed-price structure and an ultimate completion date of February 2, 2026. The award carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania.
This delivery order operates under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion single-award vehicle that extends through December 2031 and serves as the primary mechanism for supplying comprehensive pharmaceutical products and medical supplies to support global military healthcare programs. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains, enabling efficient fulfillment of essential pharmaceutical requirements for military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F4E7T?
SPE2DR26F4E7T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F4E7T worth?
The government has obligated $24,876 on SPE2DR26F4E7T.
Is contract SPE2DR26F4E7T an order under another contract?
Yes. SPE2DR26F4E7T is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4E7T competed?
The extent of competition for SPE2DR26F4E7T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award